Dear Olive,
CADTH of Canada has recently completed a major piece of work on self-monitoring
of blood glucose (SMBG), in 2009:
http://www.cadth.ca/index.php/en/compus/blood-glucose
The key messages from the CADTH work are:
1. For people with type 1 or type 2 diabetes who are using basal-bolus insulin
regimens, SMBG should be individualized to guide adjustments in insulin therapy
to achieve optimal blood glucose control.
2. In adults with type 2 diabetes who are using basal insulin, SMBG should be
individualized, but testing of up to 14 times per week should be sufficient for
most patients at most times.
3. Most adults with type 2 diabetes managed on oral antidiabetes drugs do not
require routine SMBG. Periodic testing in selected patients (e.g., those with
unstable glucose levels, acute illness, pharmacotherapy changes, risk of
hypoglycemia with insulin secretagogues like glyburide) should be linked to
specific patient actions (e.g., prevention or management of hypoglycemia,
selfdirected
dosage adjustment).
4. Most adults with type 2 diabetes controlled by diet alone should not require
routine SMBG.
Background on Self-Monitoring of Blood Glucose (Report and Findings-at-a-Glance)
* Summary Reports:
Executive Summary (9 pages. re: clinical reports)
Project in Brief (one page, re: clinical reports)
* Final reports:
Gap Analysis and Key Messages for the Prescribing and Use of Blood Glucose Test
Strips for the Self-Monitoring of Blood Glucose. Optimal Therapy Report - COMPUS
2009; 3(7)
Optimal Therapy Recommendations for the Prescribing and Use of Blood Glucose
Test Strips. Optimal Therapy Report – COMPUS 2009, 3(6)
Current Practice Analysis of Health Care Providers and Patients on
Self-Monitoring of Blood Glucose. Optimal Therapy Report - COMPUS 2009; 3(5)
Current Utilization of Blood Glucose Test Strips in Canada. Optimal Therapy
Report – COMPUS 2009; 3(4)
Cost Effectiveness of Blood Glucose Test Strips in the Management of Adult
Patients with Diabetes Mellitus. Optimal Therapy Report – COMPUS 2009; 3(3)
Systematic Review of Use of Blood Glucose Test Strips for the Management of
Diabetes Mellitus. Optimal Therapy Report – COMPUS 2009; 3(2)
Use of Blood Glucose Test Strips for the Management of Diabetes Mellitus –
Project Protocol. Optimal Therapy Report - COMPUS 2008; 3(1)
Regards,
Ash
Dr Ash Paul
Medical Director
NHS Bedfordshire
21 Kimbolton Road
Bedford
MK40 2AW
Tel no: 01234897224
Email: [log in to unmask]
________________________________
From: Olive Goddard <[log in to unmask]>
To: [log in to unmask]
Sent: Tue, 23 November, 2010 12:38:04
Subject: Self-minitoring of Blood Glucose Conference
Apologies for any cross postings
Dear Colleague
The MaDOx group [Monitoring and Diagnosis Oxford] is holding a one day
conference on Self-monitoring of Blood Glucose in Non-insulin Treated Type 2
diabetes on December 2nd 2010 at Rhodes house in Oxford.
The objective is to present up to date information of what is known about SMBG
and in particular explore if it is likely to be effective in selected groups.
Please go to www.madox.org for more information and register your interest.
We look forward to hearing from you soon.
2nd Dec 2010
Rhodes House
University of Oxford
Self-monitoring
Blood Glucose in Non-Insulin Treated Type 2 diabetes
Conference
Hosted by MaDOx Monitoring and Diagnosis Oxford
Speakers:
· Prof Norman Waugh University of Aberdeen
· Dr Rafael PereraUniversity of Oxford
· Dr William PolonskyBehavioural Diabetes Institute
· Prof Andrew Farmer University of Oxford
· Dr Maurice O’Kane University of Ulster
· Prof Lionel Tarassenko University of Oxford
· Dr Simon Heller University of Sheffield
· Dr Julia Lawton University of Edinburgh
· Dr Stuart Smellie Bishop Auckland General Hospital
· Hugo Tewson Patient representative
The conference is aimed at both clinicians and patients interested in learning
about the state-of-the-art in blood glucose self-monitoring, and contributing to
the future directions of research and practice.
Further Information and to register your interest:
Email: [log in to unmask]
[log in to unmask]
Tel: 01865 289322
Ruth Davis
Programme manager
Oxford Centre for Monitoring and Diagnosis (MaDOx)
Dept of Primary Health Care
Old Road Campus
Roosevelt Dr, Headington, Oxford
OX3 7FL
Tel: 01865 289322
www.madox.org or www.monitoringanddiagnosis.com
